Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe
Allan Jones, Jakob E. Bardram, Per Bækgaard, Claus Lundgaard Cramer-Petersen, Timothy Skinner, Karsten Vrangbæk, Laila Kærgaard Starr, Kirsten Nørgaard, Nanna Lind, Merete B. Christensen, Charlotte Glümer, Rui Wang‐Sattler, Michael Laxy, Erik Brander, Lutz Heinemann, Tim Heise, Freimut Schliess, Katharina Ladewig, Dagmar Kownatka
Abstract
Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel "iPDM Goes Europe" consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.